Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

By LabMedica International staff writers
Posted on 18 Nov 2026

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. More...

Brazil is an important clinical research destination, supported by its diverse patient population and experienced investigators. To strengthen local research infrastructure, a newly announced expansion will introduce clinical trial kit assembly and future laboratory operations closer to research sites and patients.

Labcorp (Burlington, NC, USA) is collaborating with Grupo Fleury (São Paulo, Brazil), one of Brazil’s leading healthcare and diagnostic groups, to expand its clinical trial operations in the country. The partnership combines Labcorp’s global central laboratory expertise with Grupo Fleury’s extensive laboratory infrastructure, scientific capabilities, and established presence in Brazil’s healthcare sector. The collaboration aims to provide clinical trial sponsors with local operational support while maintaining consistent quality standards, scientific expertise, and data integrity across Labcorp’s global laboratory network.

The expansion will begin with local clinical trial kit assembly, scheduled to start in early 2027, followed by laboratory operations expected to launch by the end of 2027. Both operations will follow Labcorp’s established global systems, processes, and quality standards to ensure consistency in supporting multinational clinical trials.

Labcorp’s wholly owned central laboratory network currently spans North America, Europe, Asia, and Africa, with the Brazil collaboration extending its clinical trial support capabilities across five continents. By establishing local operations, the company aims to shorten kit delivery times, reduce dependence on international shipping, and improve operational efficiency for clinical trial sponsors. The additional infrastructure is also expected to strengthen support for global studies by bringing clinical trial services closer to research sites and patients throughout Brazil.

“Brazil continues to strengthen its position in global clinical research, supported by a diverse patient population, strong scientific capabilities and experienced research teams. By combining Grupo Fleury's scientific expertise, operational excellence and deep understanding of the local research environment with Labcorp's global clinical trial capabilities, we can help make clinical trials more efficient, broaden access to research opportunities and support the continued development of Brazil's clinical research ecosystem,” said Edgar Rizzatti, president of Grupo Fleury's Medical, Technical, Hospitals, New Links and Innovation Business Unit.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Urine Analyzer
respons® UDS100
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.